JPS61176546A - Fluorine-containing carbonyl compound and method for producing the same - Google Patents
Fluorine-containing carbonyl compound and method for producing the sameInfo
- Publication number
- JPS61176546A JPS61176546A JP1837585A JP1837585A JPS61176546A JP S61176546 A JPS61176546 A JP S61176546A JP 1837585 A JP1837585 A JP 1837585A JP 1837585 A JP1837585 A JP 1837585A JP S61176546 A JPS61176546 A JP S61176546A
- Authority
- JP
- Japan
- Prior art keywords
- group
- fluorine
- aliphatic
- carbon atoms
- less carbon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052731 fluorine Inorganic materials 0.000 title claims description 35
- 239000011737 fluorine Substances 0.000 title claims description 26
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 title claims description 25
- 150000001728 carbonyl compounds Chemical class 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 125000001931 aliphatic group Chemical group 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 125000001153 fluoro group Chemical group F* 0.000 claims description 9
- 125000006162 fluoroaliphatic group Chemical group 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 11
- 239000000203 mixture Substances 0.000 description 8
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 150000002596 lactones Chemical group 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 230000002906 microbiologic effect Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000004293 19F NMR spectroscopy Methods 0.000 description 1
- -1 5-hydroxy- 4-Trifluoromethyl-2-hexanone Chemical compound 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- ABDBNWQRPYOPDF-UHFFFAOYSA-N carbonofluoridic acid Chemical compound OC(F)=O ABDBNWQRPYOPDF-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 150000002221 fluorine Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 150000007934 α,β-unsaturated carboxylic acids Chemical class 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
イ、産業上の利用分野
本発明は含フツ素カルボニル化合物及びその製造方法に
関するものである。DETAILED DESCRIPTION OF THE INVENTION A. Field of Industrial Application The present invention relates to a fluorine-containing carbonyl compound and a method for producing the same.
口、従来技術
近時、生体系において、微生物によっては殆んど分解さ
れることのないハロゲン含有化合物の微生物学的挙動に
関心が寄せられている。BACKGROUND OF THE INVENTION Recently, there has been interest in the microbiological behavior of halogen-containing compounds that are hardly degraded by microorganisms in biological systems.
本発明者は、特願昭57−151010号において既に
、次式に示す如くにして含フツ素カルボニル化合物を活
性なパン酵母によって不斉還元し、立体構造のコントロ
ール下に含フツ素アルコールを微生物学的に得る方法を
提案した。The present inventor has already reported in Japanese Patent Application No. 57-151010 that a fluorine-containing carbonyl compound was asymmetrically reduced using active baker's yeast as shown in the following formula, and a fluorine-containing alcohol was converted into microorganisms under the control of the steric structure. We proposed a method to obtain it scientifically.
(但、Rfはペルフルオロアルキル基、Rはアルキル基
又はCHz Cot Et等)更にまた、フッ素化学に
ついての最近の文献によれば、含フツ素生物活性分子の
不斉合成に有用なキラルな合成手段が注目されている(
G、B。(However, Rf is a perfluoroalkyl group, R is an alkyl group, or CHz Cot Et, etc.) Furthermore, according to recent literature on fluorine chemistry, chiral synthetic means useful for asymmetric synthesis of fluorine-containing bioactive molecules is attracting attention (
G.B.
Quistad、 D、 C,Cerf、 D、 A、
5chooley 。Quistad, D.C., Cerf, D.A.
5chooley.
and G、 B、 5taal、 Nature、
289. 176(1981〕等)。and G, B, 5taal, Nature,
289. 176 (1981] etc.).
本発明者は、含フツ素化合物の微生物学的変換について
検討を加えたところ、例えば2,2.2− )リフルオ
ロエタノールを用いたエナンチオトビツクな段階反応で
、微生物学的に炭素−炭素間結合を生ぜしめ得ることを
見出し、本発明に到達した。The present inventor investigated the microbiological conversion of fluorine-containing compounds and found that, for example, an enantiotoxic stepwise reaction using 2,2.2-) refluoroethanol resulted in microbiological carbon-carbon The present invention has been achieved based on the discovery that it is possible to generate inter-bonds.
これまでに知られているトリフルオロメチル化剤の中で
、2,2.2− トリフルオロエタノールはアルコール
脱水素酵素の自殺物質(suicide 1nacti
vator)として知られている(D、 C,Ande
rson andF、 W、 Dahlquist、
Biochemistry 、 2土。Among the trifluoromethylating agents known so far, 2,2,2-trifluoroethanol is the suicide substance of alcohol dehydrogenase.
known as (D, C, Ande vator)
rson and F, W, Dahlquist,
Biochemistry, 2 Sat.
3569 (1982)) 。3569 (1982)).
ハ0発明の目的
本発明の目的は、フッ素を所定の分子内位置に有し、光
学的に活性で生理活性に優れた新規な含フツ素カルボニ
ル化合物を提供することにある。Object of the Invention An object of the present invention is to provide a novel fluorine-containing carbonyl compound having fluorine at a predetermined position in the molecule and having excellent optical activity and physiological activity.
本発明の他の目的は、上記の含フツ素カルボニル化合物
を高収率かつ容易に得ることのできる製造方法を提供す
ることにある。Another object of the present invention is to provide a manufacturing method that allows the above-mentioned fluorine-containing carbonyl compound to be obtained easily in high yield.
二0発明の構成及びその作用効果
即ち、本発明は、
一般式:
〔但、RI 、Rを及びR3のうちの1つは低級フルオ
ロ脂肪族基又はフッ素原子であり、他は水素原子、ハロ
ゲン原子又は脂肪族若しくは芳香族基;R4は水素原子
、脂肪族若しくは芳香族基又は−OR’基(但、R5は
水素原子又は脂肪族若しくは芳香族基である。)であり
、R2が低級フルオロ脂肪族基又はフッ素原子でない場
合にはR4と結合して環を形成してもよ(、R4が−O
R’基である場合にはγ位の水酸基(−OH)との間で
の脱R’OHによってエーテル結合を形成してもよい。20 Structure of the invention and its effects, that is, the present invention has the general formula: atom or an aliphatic or aromatic group; R4 is a hydrogen atom, an aliphatic or aromatic group, or an -OR' group (wherein R5 is a hydrogen atom or an aliphatic or aromatic group), and R2 is a lower fluoro group; If it is not an aliphatic group or a fluorine atom, it may be combined with R4 to form a ring (if R4 is -O
When it is an R' group, an ether bond may be formed by removal of R'OH between the hydroxyl group (-OH) at the γ-position.
〕
で表わされる含フツ素カルボニル化合物に係るものであ
る。] This relates to a fluorine-containing carbonyl compound represented by the following.
この含フツ素カルボニル化合物は分子内の所定位置(β
又は1位)に低級フルオロ脂肪族基を有し、特にγ位の
炭素原子がキラルであるため、優れた生理活性作用、例
えば抗炎症剤や抗生物質の半合成中間体としての効能を
発揮することのできるものである。これは特に、上記の
脱R’OHによるエーテル結合でラクトン環を形成する
場合に“ 顕著である。This fluorine-containing carbonyl compound is located at a predetermined position within the molecule (β
It has a lower fluoroaliphatic group at the 1-position), and the carbon atom at the γ-position is chiral, so it exhibits excellent physiological activity, such as efficacy as a semi-synthetic intermediate for anti-inflammatory agents and antibiotics. It is something that can be done. This is particularly noticeable when a lactone ring is formed by an ether bond due to the above-mentioned R'OH removal.
本発明はまた、上記含フツ素カルボニル化合物を効果的
に得る方法として、
一般式:
%式%
で表わされるアルコールと、
一般式:
で表わされるα、β−不飽和カルボニル化合物とを酵母
の存在下で反応させ、これによって、一般式:
%式%
〔但、上記において、R1、R2及びR3のうちの1つ
は低級フルオロ脂肪族基又はフッ素原子であり、他は水
素原子、ハロゲン原子又は脂肪族若しくは芳香族基;R
4は水素原子、脂肪族若しくは芳香族基又は−OR’基
(但、R%は水素原子又は脂肪族若しくは芳香族基であ
る。)であり、R2が低級フルオロ脂肪族基又はフッ素
原子でない場合にはR4と結合して環を形成してもよく
、R4が−OR’基である場合にはγ位の水酸基(−O
H)との間での脱R’OHによってエーテル結合を形成
してもよい。〕
で表わされる含フツ素カルボニル化合物を得る含フツ素
カルボニル化合物の製造方法も提供するものである。The present invention also provides a method for effectively obtaining the above-mentioned fluorine-containing carbonyl compound by combining an alcohol represented by the general formula: % formula % and an α,β-unsaturated carbonyl compound represented by the general formula in the presence of yeast. % [However, in the above, one of R1, R2, and R3 is a lower fluoroaliphatic group or a fluorine atom, and the others are a hydrogen atom, a halogen atom, or a fluorine atom. Aliphatic or aromatic group; R
4 is a hydrogen atom, an aliphatic or aromatic group, or an -OR' group (however, R% is a hydrogen atom or an aliphatic or aromatic group), and when R2 is not a lower fluoroaliphatic group or a fluorine atom may be combined with R4 to form a ring, and when R4 is -OR' group, the hydroxyl group at the γ position (-O
An ether bond may be formed by removal of R'OH between H). ] The present invention also provides a method for producing a fluorine-containing carbonyl compound for obtaining a fluorine-containing carbonyl compound represented by the following.
この方法によれば、上記アルコールとα、β−不飽和カ
ルボニル化合物との反応に際し、微生物(特にパン酵母
)を作用させると、本発明の含フツ素カルボニル化合物
を容易にしかも高収率に得ることができる。According to this method, the fluorine-containing carbonyl compound of the present invention can be easily obtained in high yield by allowing microorganisms (especially baker's yeast) to act upon the reaction between the alcohol and the α,β-unsaturated carbonyl compound. be able to.
本発明の含フツ素カルボニル化合物及びその製造方法に
おいて、R1,R2及びR3のうちの1つが低級フルオ
ロ脂肪族基、特に炭素原子数10以下の低級フルオロア
ルキル基(Rf)であるのがよいが、こうしたRf(特
にペルフルオロアルキル基)は、一般式: CF !
(CF z )n−又は(CF3 )zcF (CFz
) 、1−で表わされるもの、例えばCF :l−1
CFzCFz−1CFs(CFz)z−1CFz(CF
z )2−1CF !(CF z)a−1CFa(CF
z )s−1CF 3(CF tub −1(CF、
)! CF−1(CFzh CFCFz −1(CF
s)z CF(CFz)z −1(CFs)z CF(
CFz)s −等がある。これら以外に、Rfとして含
フッ素アルケ丹ル基、例えばCFt =CFCFt−1
CF3CF=CF−等も適用可能である。In the fluorine-containing carbonyl compound and the method for producing the same of the present invention, one of R1, R2 and R3 is preferably a lower fluoroaliphatic group, particularly a lower fluoroalkyl group (Rf) having 10 or less carbon atoms. , such Rf (particularly perfluoroalkyl groups) has the general formula: CF!
(CFz)n- or (CF3)zcF (CFz
), 1-, for example CF:l-1
CFzCFz-1CFs(CFz)z-1CFz(CF
z)2-1CF! (CF z)a-1CFa(CF
z)s-1CF3(CFtub-1(CF,
)! CF-1(CFzh CFCFz-1(CF
s)z CF(CFz)z −1(CFs)z CF(
CFz)s -, etc. In addition to these, Rf is a fluorine-containing alkenyl group, such as CFt=CFCFt-1
CF3CF=CF- etc. are also applicable.
また、R’、R”及びR3の中でRfでない基は、炭素
原子数10以下の低級脂肪族基であり、CR3(CHz
)、1−又は(CHs)z CH(cHt)+%−で表
わされるアルキル基、又はCH! = CHCHz−1
CH,CH=CH−等のアルケニル基が適用可能である
。また、フェニル基等の芳香族基も適用可能である。Further, among R', R'' and R3, the group other than Rf is a lower aliphatic group having 10 or less carbon atoms, and CR3 (CHz
), 1- or (CHs)z CH(cHt)+%-, or CH! = CHCHHz−1
Alkenyl groups such as CH, CH=CH-, etc. are applicable. Furthermore, aromatic groups such as phenyl groups are also applicable.
また、上記のR4、R8もRI SR1、R:lと同様
の上記に例示した低級脂肪族基であってよい。Furthermore, R4 and R8 above may also be the lower aliphatic groups exemplified above, similar to RI SR1 and R:1.
本発明の製造方法は特に、pH4〜7.5の弱酸性下(
望ましくはpH5,5〜6.2)で実施するのが、不要
な他の反応を生起せしめない点で望ましい。また、反応
温度も酵母の作用を効率良く生せしめる上で25〜40
℃とするのがよ<、35〜37℃とするのが最適である
。The production method of the present invention is particularly suitable for use under weakly acidic conditions of pH 4 to 7.5 (
It is desirable to carry out the reaction at a pH of 5.5 to 6.2) in order to avoid causing other unnecessary reactions. In addition, the reaction temperature is 25 to 40°C, which is necessary for efficient yeast action.
The temperature is preferably 35 to 37°C.
他の反応条件としては、溶媒は水でよく、反応時間は数
日〜1週間程度であるのがよい。As for other reaction conditions, the solvent may be water, and the reaction time is preferably about several days to one week.
次に本発明を反応式に従ってより詳細に説明する。Next, the present invention will be explained in more detail according to the reaction formula.
まず、α、β−不飽和ケトン1を用い、次式に従って微
生物学的変換を行なう。First, a microbiological transformation is carried out using α,β-unsaturated ketone 1 according to the following formula.
種々のケトンを用いた場合の結果を下記表−1に示した
が、1からは他のアルコール3及び4が相当量生成する
と同時に、目的とする光学活性な含フツ素カルビノール
2が生成される。この反応は2.2.2−トリフルオロ
エタノールを用いない場合よりもゆっくりと進行する。The results obtained when various ketones were used are shown in Table 1 below. From 1, considerable amounts of other alcohols 3 and 4 were produced, and at the same time, the desired optically active fluorine-containing carbinol 2 was produced. Ru. This reaction proceeds more slowly than without 2.2.2-trifluoroethanol.
カルビノール2は種々の分析データにより同定されたが
、特に、I9FNMRスペクトルによれば、CF、基が
61.3 ppm (外部標準CFs Cot H)で
ダブレットに現われる(C)(OH水素によりスプリン
ト)。Carbinol 2 was identified by various analytical data, but in particular, according to the I9F NMR spectrum, the CF group appears in a doublet at 61.3 ppm (external standard CFs Cot H) (C) (sprinted with OH hydrogen). .
光学純度は、アルコールを光学活性なペルフルオロカル
ボン酸でジアステレオメリックなエステルに転化した後
の”FNMRによって測定した。Optical purity was determined by FNMR after converting the alcohol to a diastereomeric ester with an optically active perfluorocarboxylic acid.
上記反応は、β−置換α、β−不飽和ケトン5を使用し
た場合も同様に進行する。The above reaction proceeds similarly when β-substituted α,β-unsaturated ketone 5 is used.
R” 0
旦
一方、種々のα、β−不飽和エステル急を用い、パン酵
母の存在下で反応させたところ、次のように、中間生成
物環を経てラクトンUを生成する。On the other hand, when various α,β-unsaturated esters were reacted in the presence of baker's yeast, lactone U was produced through the intermediate product ring as shown below.
この際、例えば7日間の発酵後に炭素−炭素二重結合が
還元されて、新規な中間生成物枳がまず生成する。この
反応条件は上述と同様である。In this case, for example after fermentation for 7 days, the carbon-carbon double bond is reduced and a new intermediate product is first formed. The reaction conditions are the same as described above.
■
生成物の中で特にラクトンlは抗炎症剤としての生理活
性作用を有し、かつ分子中のR8基が比較的長鎖である
と抗生物質としての効能を期待できる。(2) Among the products, lactone 1 in particular has a physiologically active action as an anti-inflammatory agent, and if the R8 group in the molecule is relatively long chain, it can be expected to be effective as an antibiotic.
(以下余白、次頁につづく。)
次に、上記した反応とは異なり、出発原料として含フッ
素α、β−不飽和ケトンはとエタノールとを用い、これ
らを上記と同様にパン酵母の存在下で反応させても、本
発明の化合物1を得ることができる。(The following margins are continued on the next page.) Next, unlike the reaction described above, fluorine-containing α,β-unsaturated ketones and ethanol were used as starting materials, and these were mixed in the presence of baker's yeast in the same manner as above. Compound 1 of the present invention can also be obtained by reacting with
13目
臣
或いは、含フッ素α、β−不飽和カルボン酸エステル旧
を用いても、次のように中間生成物1を経て本発明のラ
クトン旧が得られる。Even if the 13th compound or a fluorine-containing α,β-unsaturated carboxylic acid ester is used, the lactone of the present invention can be obtained through intermediate product 1 as follows.
ノゝ 埠 沼果を下記表−2にまとめて示した。Now Pier The mulberry fruits are summarized in Table 2 below.
c以下余白、次頁につづく。)
上記した如く、本発明に従って、含フツ素化合物中に新
しい合成ルートにて炭素−炭素結合を微生物学的に導入
することが可能となり、かつ難分解性の含フツ素材料を
変化自在な分子に微生物学的に変換することができる。Margin below c, continued on next page. ) As described above, according to the present invention, it has become possible to microbiologically introduce carbon-carbon bonds into fluorine-containing compounds by a new synthetic route, and it has become possible to transform difficult-to-degradable fluorine-containing materials into flexible molecules. can be microbiologically converted into
ホ、実施例
以下、本発明を具体的な実施例によって更に詳細に説明
するが、以下の実施例は本発明を限定するものではなく
、その技術的思想に基いて種々変更が可能である。E. Examples Hereinafter, the present invention will be explained in more detail with reference to specific examples, but the following examples do not limit the present invention, and various changes can be made based on the technical idea thereof.
去施炎上
1/15モルのNazHPOm水溶液(60mJ)と1
/15モルのKH2PO,水溶液(540nl)とから
調製された緩衝液(600m1、p H5,9)中に、
活性なパン酵母(オリエンタルイースト社製)(50g
)と可溶性デンプン(和光第1グレード)(75g)と
を懸濁せしめた。この懸濁液をジャーファーメンタ−(
東京理化器械■製)中で、35〜36℃で60分間攪拌
した。この混合液に、メチルビニルケトン(2,1g、
30 mmol と2.2.2− )リフルオロエタ
ノール(10g 、 IQOmmo 1 )とを添加し
、次いで混合物全体を35〜36℃で攪拌した。3日間
攪拌後、パン酵母(50g )と可溶性デンプン(75
g)とを追加して添加し、4日間攪拌を続けた。そして
この攪拌混合物中に、P−713(第1工業製薬社製)
から調製された200ppmの凝集剤溶液(100nl
りを数分間かけて添加した。1時間放置後、混合物を3
%HCIで酸性とし、更に沈澱物を濾過により分離した
。油層をジエチルエーテルで抽出し、エーテル側の抽出
物を無水硫酸マグネシウムで乾燥後、溶媒を留去した。A 1/15 mol NazHPOm aqueous solution (60 mJ) and 1
/15 mol of KH2PO, in a buffer solution (600 ml, pH 5,9) prepared from an aqueous solution (540 nl),
Active baker's yeast (manufactured by Oriental Yeast) (50g)
) and soluble starch (Wako Daiichi Grade 1) (75 g) were suspended. Transfer this suspension to a jar fermenter (
The mixture was stirred at 35 to 36° C. for 60 minutes in a tube (manufactured by Tokyo Rikakikai Co., Ltd.) for 60 minutes. Add methyl vinyl ketone (2.1 g,
30 mmol and 2.2.2-) refluoroethanol (10 g, IQOmmo1) were added and the whole mixture was then stirred at 35-36<0>C. After stirring for 3 days, baker's yeast (50g) and soluble starch (75g)
g) was further added and stirring was continued for 4 days. Then, in this stirring mixture, P-713 (manufactured by Daiichi Kogyo Seiyaku Co., Ltd.)
A 200 ppm flocculant solution (100 nl) prepared from
was added over several minutes. After standing for 1 hour, mix the mixture with 3
% HCI and the precipitate was separated by filtration. The oil layer was extracted with diethyl ether, and the ether extract was dried over anhydrous magnesium sulfate, and then the solvent was distilled off.
この結果、対応する6、6.ロートリフルオロ−5−ヒ
ドロキシ−2−ヘキサノンが26%の収率で得られ、そ
の沸点はbp92〜94℃15mmHgであり、〔αo
)(neat)は−12,1、光学純度は93%eeで
あった。As a result, the corresponding 6,6. Lotrifluoro-5-hydroxy-2-hexanone was obtained with a yield of 26%, its boiling point was bp 92-94°C 15 mmHg, [αo
) (neat) was -12.1, and the optical purity was 93%ee.
スJJL影
実施例1において、出発原料としてメチルビニルケトン
に代えてシクロヘキサノン(2,9g、 30mmo
l )が用いられ、上記と同様に反応させた。In Example 1, cyclohexanone (2.9 g, 30 mmol) was used instead of methyl vinyl ketone as the starting material.
l) was used and reacted in the same manner as above.
蒸留後に、2−(β、β、β−トリフルオローα−ヒド
ロキシ)エチルシクロヘキサノンが38%の収率で得ら
れ、そのジアステレオ混合比は19FNMRシグナル強
度から92二8であり、M” (m/e)は196で
あった。他のピークもマススペクトル中に観察された。After distillation, 2-(β,β,β-trifluoroα-hydroxy)ethylcyclohexanone was obtained with a yield of 38%, and its diastereomixing ratio was 9228 from the 19F NMR signal intensity, and M” (m /e) was 196. Other peaks were also observed in the mass spectrum.
大嵐医主
実施例1において、メチルビニルケトンに代えてエチル
アクリレ−) (3g、 30 mmolが用いられ、
上記と同様に反応させた。蒸留により、5−トリフルオ
ロメチル−γ−ブチロラクトンが47%の収率で得られ
、゛その光学純度は79%eeであり、(αD )
(neat )は+13.6であった。他のピークもマ
ススペクトル中に観察された。In Daiarashi Medical Example 1, ethyl acrylate (3 g, 30 mmol) was used instead of methyl vinyl ketone,
The reaction was carried out in the same manner as above. By distillation, 5-trifluoromethyl-γ-butyrolactone was obtained with a yield of 47%, its optical purity was 79%ee, and (αD)
(neat) was +13.6. Other peaks were also observed in the mass spectrum.
叉施五工
1/15モルのN a z HP O4水溶液(60n
+jりと1 / 15モRv(D K Ht P O4
水溶液(540+*jりとから調製された緩衝液(60
0mll Sp H5,9)中に、活性なパン酵母(オ
リエンタルイースト社製)(75g)と可溶性デンプン
(和光第1グレード)(115g)とを懸濁せしめた。1/15 mol N az HP O4 aqueous solution (60n
+j Rito 1/15MoRv (D K Ht P O4
Buffer solution prepared from aqueous solution (540+*j)
Active baker's yeast (manufactured by Oriental Yeast Co., Ltd.) (75 g) and soluble starch (Wako Daiichi Grade 1) (115 g) were suspended in 0 ml Sp H5,9).
この懸濁液をジャーファーメンタ−(東京理化器械■製
)中で35〜36℃で60分間攪拌した。この混合液に
、5.5.5−)リフルオロ−3−ペンテン−2−オン
(4,1g、 30 mmol) とエタノール(15
g )とを添加し、次いで混合物全体を35〜36℃で
攪拌した。This suspension was stirred at 35-36° C. for 60 minutes in a jar fermenter (manufactured by Tokyo Rikakikai ■). To this mixture were added 5.5.5-)lifluoro-3-penten-2-one (4.1 g, 30 mmol) and ethanol (15
g) was added and the whole mixture was then stirred at 35-36°C.
3日間攪拌後、パン酵母(75g )と可溶性デンプン
(115g)とを追加して添加し、4日間攪拌を続けた
。そしてこの攪拌混合物中に、P−713(第1工業製
薬社製)から調製された200ppmの凝集剤溶液<2
00ta il )を数分間かけて添加した。1時間放
置後、混合物を3%HC2で酸性とし、更に沈澱物を濾
過により分離した。油層をジエチルエーテルで抽出し、
エーテル側の抽出物を無水硫酸マグネシウムで乾燥後、
溶媒を留去した。この結果、対応する5−ヒドロキシ−
4−トリフルオロメチル−2−ヘキサノンが62%の収
率で得られ、その質量スペクトルはM” (m/ e
) 184であった。After stirring for 3 days, additional baker's yeast (75 g) and soluble starch (115 g) were added and stirring continued for 4 days. In this stirred mixture, a 200 ppm flocculant solution prepared from P-713 (manufactured by Daiichi Kogyo Seiyaku Co., Ltd.) <2
00tail) was added over several minutes. After standing for 1 hour, the mixture was acidified with 3% HC2 and the precipitate was separated by filtration. Extract the oil layer with diethyl ether,
After drying the ether extract with anhydrous magnesium sulfate,
The solvent was distilled off. As a result, the corresponding 5-hydroxy-
4-Trifluoromethyl-2-hexanone was obtained in 62% yield and its mass spectrum was M” (m/e
) It was 184.
他のピークは同スペクトル中に観測された。Other peaks were observed in the same spectrum.
裏施班工
実施例4において、出発原料として5.5.5− )リ
フルオロ−3−ペンテン−2−オンの代りに、エチル(
β−トリフルオロメチル)アクリレート(5g、30
mmojりが用いられ、上記と同様に反応させた。蒸留
後に、4−トリフルオロメチル−5−メチル−T−ブチ
ロラクトンが56%の収率で得られ、そのM十 (m/
e)は168であり、他のピークはマススペクトルで観
察された。In back coating Example 4, ethyl(
β-trifluoromethyl)acrylate (5g, 30
mmoj was used and the reaction was carried out in the same manner as above. After distillation, 4-trifluoromethyl-5-methyl-T-butyrolactone was obtained with a yield of 56% and its M
e) was 168 and other peaks were observed in the mass spectrum.
Claims (1)
ルオロ脂肪族基又はフッ素原子であり、他は水素原子、
ハロゲン原子又は脂肪族若しくは芳香族基;R^4は水
素原子、脂肪族若しくは芳香族基又は−OR^5基(但
、R^5は水素原子又は脂肪族若しくは芳香族基である
。)であり、R^2が低級フルオロ脂肪族基又はフッ素
原子でない場合にはR^4と結合して環を形成してもよ
く、R^4が−OR^5基である場合にはγ位の水酸基
(−OH)との間での脱R^5OHによってエーテル結
合を形成してもよい。〕 で表わされる含フッ素カルボニル化合物。 2、R^1、R^2及びR^3のうちの1つが炭素原子
数10以下の低級フルオロアルキル基であり、他が炭素
原子数10以下の低級脂肪族基である、特許請求の範囲
の第1項に記載した化合物。 3、R^4が炭素原子数10以下の低級脂肪族基である
、特許請求の範囲の第1項に記載した化合物。 4、R^5が炭素原子数10以下の低級脂肪族基である
、特許請求の範囲の第1項に記載した化合物。 5、一般式: R^1CH_2OH で表わされるアルコールと、 一般式: ▲数式、化学式、表等があります▼ で表わされるα、β−不飽和カルボニル化合物とを酵母
の存在下で反応させ、これによって、一般式: ▲数式、化学式、表等があります▼ 〔但、上記において、R^1、R^2及びR^3のうち
の1つは低級フルオロ脂肪族基又はフッ素原子であり、
他は水素原子、ハロゲン原子又は脂肪族若しくは芳香族
基;R^4は水素原子、脂肪族若しくは芳香族基又は−
OR^5基(但、R^5は水素原子又は脂肪族若しくは
芳香族基である。)であり、R^2が低級フルオロ脂肪
族基又はフッ素原子でない場合にはR^4と結合して環
を形成してもよく、R^4が−OR^5基である場合に
はγ位の水酸基(−OH)との間での脱R^5OHによ
ってエーテル結合を形成してもよい。〕 で表わされる含フッ素カルボニル化合物を得る含フッ素
カルボニル化合物の製造方法。 6、pH4〜7.5、温度25〜40℃の条件下で反応
を行なわせる、特許請求の範囲の第5項に記載した方法
。 7、R^1、R^2及びR^3のうちの1つが炭素原子
数10以下の低級フルオロアルキル基であり、他が炭素
原子数10以下の低級脂肪族基である、特許請求の範囲
の第5項に記載した方法。 8、R^4が炭素原子数10以下の低級脂肪族基である
、特許請求の範囲の第5項に記載した方法。 9、R^5が炭素原子数10以下の低級脂肪族基である
、特許請求の範囲の第5項に記載した方法。[Claims] 1. General formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [However, one of R^1, R^2 and R^3 is a lower fluoroaliphatic group or a fluorine atom. Yes, others are hydrogen atoms,
A halogen atom or an aliphatic or aromatic group; R^4 is a hydrogen atom, an aliphatic or aromatic group, or an -OR^5 group (wherein R^5 is a hydrogen atom or an aliphatic or aromatic group); If R^2 is not a lower fluoroaliphatic group or a fluorine atom, it may be combined with R^4 to form a ring, and if R^4 is -OR^5 group, the γ-position An ether bond may be formed by removing R^5OH between the hydroxyl group (-OH). ] A fluorine-containing carbonyl compound represented by: 2. The claim that one of R^1, R^2 and R^3 is a lower fluoroalkyl group having 10 or less carbon atoms, and the other is a lower aliphatic group having 10 or less carbon atoms. The compound described in item 1. 3. The compound described in claim 1, wherein R^4 is a lower aliphatic group having 10 or less carbon atoms. 4. The compound described in claim 1, wherein R^5 is a lower aliphatic group having 10 or less carbon atoms. 5. An alcohol represented by the general formula: R^1CH_2OH and an α,β-unsaturated carbonyl compound represented by the general formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ are reacted in the presence of yeast, thereby , general formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [However, in the above, one of R^1, R^2 and R^3 is a lower fluoroaliphatic group or a fluorine atom,
Others are hydrogen atoms, halogen atoms, or aliphatic or aromatic groups; R^4 is hydrogen atoms, aliphatic or aromatic groups, or -
OR^5 group (however, R^5 is a hydrogen atom or an aliphatic or aromatic group), and if R^2 is not a lower fluoroaliphatic group or a fluorine atom, it is bonded to R^4. A ring may be formed, and when R^4 is an -OR^5 group, an ether bond may be formed by removal of R^5OH between the hydroxyl group (-OH) at the γ position. ] A method for producing a fluorine-containing carbonyl compound to obtain a fluorine-containing carbonyl compound represented by the following. 6. The method according to claim 5, wherein the reaction is carried out at a pH of 4 to 7.5 and a temperature of 25 to 40°C. 7. Claims in which one of R^1, R^2 and R^3 is a lower fluoroalkyl group having 10 or less carbon atoms, and the others are lower aliphatic groups having 10 or less carbon atoms. The method described in Section 5. 8. The method according to claim 5, wherein R^4 is a lower aliphatic group having 10 or less carbon atoms. 9. The method according to claim 5, wherein R^5 is a lower aliphatic group having 10 or less carbon atoms.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1837585A JPS61176546A (en) | 1985-01-31 | 1985-01-31 | Fluorine-containing carbonyl compound and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1837585A JPS61176546A (en) | 1985-01-31 | 1985-01-31 | Fluorine-containing carbonyl compound and method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61176546A true JPS61176546A (en) | 1986-08-08 |
Family
ID=11969964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1837585A Pending JPS61176546A (en) | 1985-01-31 | 1985-01-31 | Fluorine-containing carbonyl compound and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61176546A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009972A1 (en) * | 1989-02-27 | 1990-09-07 | Nippon Oil And Fats Co., Ltd. | Fluoroalkyl derivative and production thereof |
-
1985
- 1985-01-31 JP JP1837585A patent/JPS61176546A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009972A1 (en) * | 1989-02-27 | 1990-09-07 | Nippon Oil And Fats Co., Ltd. | Fluoroalkyl derivative and production thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6127384B2 (en) | ||
JPS61176546A (en) | Fluorine-containing carbonyl compound and method for producing the same | |
JPH04149151A (en) | Production of 4-bromo-3-hydroxybutyric acid ester derivative | |
JP3129776B2 (en) | Method for producing optically active α-hydroxyalkene derivative | |
DE69711334T2 (en) | Optically active alcohol and process for its production | |
JP2002171994A (en) | Method for producing optically active tetrahydrofuran-2-carboxylic acid or its antipode ester | |
JP3583798B2 (en) | Method for producing optically active 2-methylbutanoic acid and derivatives thereof | |
JP2730611B2 (en) | Process for producing optically active hydroxycarbonyl halides | |
JPS61205227A (en) | Fluorine-containing hydroxy-c-alkanone and production thereof | |
EP0842915B1 (en) | Optically active alcohol and process for the production thereof | |
JP2896583B2 (en) | Optically active dicyclopentadiene | |
JPH0662872A (en) | Production of optically active alcohol | |
JPS63202398A (en) | Production of optically active cyanohydrin derivative | |
JPS63293A (en) | Method for producing optically active 4-hydroxy-2-cyclopentenone | |
JP2838529B2 (en) | New optically active compounds | |
EP0893422A1 (en) | Optically active alcohol and process for the production thereof | |
JPS6261587A (en) | Production of optically active (r)-hydroxymandelic acid ester intermediate | |
JPH04124157A (en) | Production of optically active 4-chloro-3-hydroxybutanoic acid and its ester | |
JPS63190839A (en) | Optically active alcohol compound | |
JPH0242050A (en) | Production of optically active 3,4-dihydroxybutyric acid derivative | |
JPS62226934A (en) | Norbornene derivative | |
JPH02262536A (en) | Optically active compound and its production | |
JPH0463598A (en) | Carboxylic acid having trifluoromethyl group and production thereof | |
EP0980860A1 (en) | Optically active secondary alcohol and process for the production thereof | |
JPH10195004A (en) | Optically active alcohol and its production |